To determine whether prenatal cannabis use alone increases the likelihood of fetal and neonatal morbidity and mortality.
Study Design:
We searched bibliographic databases, such as PubMed, Embase, Scopus, Cochrane reviews, PsycInfo, MEDLINE, Clinicaltrials.gov, and Google Scholar from inception through February 14, 2022. Cohort or case–control studies with prespecified fetal or neonatal outcomes in pregnancies with prenatal cannabis use. Primary outcomes were preterm birth (PTB; <37 weeks of gestation), small-for-gestational-age (SGA), birthweight (grams), and perinatal mortality. Two independent reviewers screened studies. Studies were extracted by one reviewer and confirmed by a second using a predefined template. Risk of bias assessment of studies, using the Newcastle–Ottawa Quality Assessment Scale, and Grading of Recommendations Assessment, Development, and Evaluation for evaluating the certainty of evidence for select outcomes were performed by two independent reviewers with disagreements resolved by a third. Random effects meta-analyses were conducted, using adjusted and unadjusted effect estimates, to compare groups according to prenatal exposure to cannabis use status.
Results:
Fifty-three studies were included. Except for birthweight, unadjusted and adjusted meta-analyses had similar results. We found very-low- to low-certainty evidence that cannabis use during pregnancy was significantly associated with greater odds of PTB (adjusted odds ratio [aOR], 1.42; 95% confidence interval [CI], 1.19 to 1.69; I2, 93%; p=0.0001), SGA (aOR, 1.76; 95% CI, 1.52 to 2.05; I2, 86%; p<0.0001), and perinatal mortality (aOR, 1.5; 95% CI, 1.39 to 1.62; I2, 0%; p<0.0001), but not significantly different for birthweight (mean difference, −40.69 g; 95% CI, −124.22 to 42.83; I2, 85%; p=0.29). Because of substantial heterogeneity, we also conducted a narrative synthesis and found comparable results to meta-analyses.
Conclusion:
Prenatal cannabis use was associated with greater odds of PTB, SGA, and perinatal mortality even after accounting for prenatal tobacco use. However, our confidence in these findings is limited. Limitations of most existing studies was the failure to not include timing or quantity of cannabis use. This review can help guide health care providers with counseling, management, and addressing the limited existing safety data.
Protocol Registration:
PROSPERO CRD42020172343.
Get full access to this article
View all access options for this article.
References
1.
Committee Opinion No. 637: Marijuana Use During Pregnancy and Lactation. Obstet Gynecol, 2015; 126(1):234–238; doi: 10.1097/01.AOG.0000467192.89321.a6
2.
MartinCE, LonginakerN, MarkK, et al.Recent trends in treatment admissions for marijuana use during pregnancy. J Add Med, 2015; 9(2):99–104.
3.
Young-WolffKC, RayGT, AlexeeffSE, et al.Rates of prenatal cannabis use among pregnant women before and during the COVID-19 pandemic. JAMA, 2021; 326(17):1745–1747.
4.
VolkowND, HanB, ComptonWM, et al.Self-reported medical and nonmedical cannabis use among pregnant women in the United States. JAMA, 2019; 322(2):167–169.
5.
ElSohlyMA, ChandraS, RadwanM, et al.A comprehensive review of cannabis potency in the united states in the last decade. Biol Psychiatry Cogn Neurosci Neuroimaging, 2021; 6(6):603–606; doi: 10.1016/j.bpsc.2020.12.016
6.
AbuseS, AdministrationMHS. Results from the 2013 National Survey on Drug Use and Health: Summary of national findings. NSDUH Series H-48, HHS Publication No (SMA) 14-4863. 2014; 1–143.
7.
BeattyJR, SvikisDS, OndersmaSJ. Prevalence and perceived financial costs of marijuana versus tobacco use among urban low-income pregnant women. J Add Res Therapy, 2012; 3(4):1000135.
8.
MooreDG, TurnerJD, ParrottAC, et al.During pregnancy, recreational drug-using women stop taking ecstasy (3, 4-methylenedioxy-N-methylamphetamine) and reduce alcohol consumption, but continue to smoke tobacco and cannabis: Initial findings from the Development and Infancy Study. J Psychopharmacol, 2010; 24(9):1403–1410.
9.
PasseyME, Sanson-FisherRW, D'EsteCA, et al.Tobacco, alcohol and cannabis use during pregnancy: Clustering of risks. Drug Alcohol Depend, 2014; 134:44–50.
10.
BrownQL, SarvetAL, ShmulewitzD, et al.Trends in marijuana use among pregnant and nonpregnant reproductive-aged women, 2002–2014. JAMA, 2017; 317(2):207–209.
11.
MetzTD, StickrathEH. Marijuana use in pregnancy and lactation: A review of the evidence. Am J Obstet Gynecol, 2015; 213(6):761–778; doi: 10.1016/j.ajog.2015.05.025
RyanS, AmmermanS, O'ConnorM. Committee on Substance Use and Prevention; Section on Breastfeeding. Marijuana use during pregnancy and breastfeeding: Implications for neonatal and childhood outcomes. Pediatrics, 2018; 142(3):e20181889.
14.
FergussonD, HorwoodL, NorthstoneK. Avon longitudinal study of pregnancy and childhood. Maternal use of cannabis and pregnancy outcome. BJOG, 2002; 109(1):21–27.
15.
El MarrounH, TiemeierH, SteegersEA, et al.Intrauterine cannabis exposure affects fetal growth trajectories: The Generation R Study. J Am Acad Child Adolesc Psychiatry, 2009; 48(12):1173–1181; doi: 10.1097/CHI.0b013e3181bfa8ee
16.
HurdYL, WangX, AndersonV, et al.Marijuana impairs growth in mid-gestation fetuses. Neurotoxicol Teratol, 2005; 27(2):221–229.
17.
AlhusenJL, LuceaMB, BullockL, et al.Intimate partner violence, substance use, and adverse neonatal outcomes among urban women. J Pediatr, 2013; 163(2):471–476; doi: 10.1016/j.jpeds.2013.01.036
18.
VarnerMW, SilverRM, Rowland HogueCJ, et al.Association between stillbirth and illicit drug use and smoking during pregnancy. Obstetr Gynecol, 2014; 123(1):113–125; doi: 10.1097/AOG.0000000000000052
19.
HayatbakhshMR, FlenadyVJ, GibbonsKS, et al.Birth outcomes associated with cannabis use before and during pregnancy. Pediatr Res, 2012; 71(2):215–219; doi: 10.1038/pr.2011.25
20.
Fernández-RuizJ, BerrenderoF, HernándezML, et al.Role of endocannabinoids in brain development. Life Sci, 1999; 65(6–7):725–736.
21.
GoldschmidtL, RichardsonGA, WillfordJ, et al.Prenatal marijuana exposure and intelligence test performance at age 6. J Am Acad Child Adolesc Psychiatry, 2008; 47(3):254–263; doi: 10.1097/CHI.0b013e318160b3f0
22.
DayNL, GoldschmidtL, ThomasCA. Prenatal marijuana exposure contributes to the prediction of marijuana use at age 14. Addiction, 2006; 101(9):1313–1322; doi: 10.1111/j.1360-0443.2006.01523.x
23.
MarchandG, MasoudAT, GovindanM, et al.Birth outcomes of neonates exposed to marijuana in utero: A systematic review and meta-analysis. JAMA Network Open, 2022; 5(1):e2145653.
24.
ConnerSN, BedellV, LipseyK, et al.Maternal marijuana use and adverse neonatal outcomes: A systematic review and meta-analysis. Obstetr Gynecol, 2016; 128(4):713–723; doi: 10.1097/AOG.0000000000001649
25.
McGowanJ, SampsonM, SalzwedelDM, et al.PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol, 2016; 75:40–46.
26.
WellsGA, SheaB, O'ConnellD, et al.The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Oxford; 2000.
27.
HigginsJP, ThomasJ, ChandlerJ, et al.Cochrane Handbook for Systematic Reviews of Interventions. John Wiley & Sons: Chichester, UK; 2019.
28.
SchererRW, SaldanhaIJ. How should systematic reviewers handle conference abstracts? A view from the trenches. Syst Rev, 2019; 8(1):1–6.
29.
GuyattGH, OxmanAD, VistGE, et al.GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 2008; 336(7650):924–926.
30.
SchünemannHJ, CuelloC, AklEA, et al.GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence. J Clin Epidemiol, 2019; 111:105–114.
31.
DerSimonianR, LairdN. Meta-analysis in clinical trials. Control Clin Trials, 1986; 7(3):177–188.
32.
SchwarzerG. Meta: An R package for meta-analysis. R News, 2007; 7(3):40–45.
33.
GrewenK, SalzwedelAP, GaoW. Functional connectivity disruption in neonates with prenatal marijuana exposure. Front Hum Neurosci, 2015; 9:601; doi: 10.3389/fnhum.2015.00601
34.
SherwoodRA, KeatingJ, KavvadiaV, et al.Substance misuse in early pregnancy and relationship to fetal outcome. Eur J Pediatr, 1999; 158(6):488–492; doi: 10.1007/s004310051126
35.
BrunoAM, BlueNR, AllshouseAA, et al.Marijuana use, fetal growth, and uterine artery Dopplers. J Matern Fetal Neonatal Med, 2022; 35(25):7717–7724.
36.
OniHT, BuultjensM, MohamedA-L, et al.Neonatal outcomes of infants born to pregnant women with substance use disorders: A multilevel analysis of linked data. Subst Use Misuse, 2022; 57(1):1–10.
37.
BandoliG, Jelliffe-PawlowskiL, SchumacherB, et al.Cannabis-related diagnosis in pregnancy and adverse maternal and infant outcomes. Drug Alcohol Depend, 2021; 225:108757.
38.
PetrangeloA, Czuzoj-ShulmanN, BalaylaJ, et al.Cannabis abuse or dependence during pregnancy: A population-based cohort study on 12 million births. J Obstetr Gynaecol Canada, 2019; 41(5):623–630.
39.
BonelloMR, XuF, LiZ, et al.Mental and behavioral disorders due to substance abuse and perinatal outcomes: A study based on linked population data in New South Wales, Australia. Int J Environ Res Public Health, 2014; 11(5):4991–5005.
40.
RayJG, ParkAL, FellDB. Mortality in infants affected by preterm birth and severe small-for-gestational age birth weight. Pediatrics, 2017; 140(6):e20171881.
41.
MartinJA, HamiltonBE, OstermanM. Births in the United States, 2020. NCHS Data Brief, 2021; 418:1–8.
42.
BoguszewskiMC, MericqV, BergadaI, et al.Latin American consensus: Children born small for gestational age. BMC Pediatr, 2011; 11(1):1–10.
43.
GunnJK, RosalesCB, CenterKE, et al.Prenatal exposure to cannabis and maternal and child health outcomes: A systematic review and meta-analysis. BMJ Open, 2016; 6(4):e009986; doi: 10.1136/bmjopen-2015-009986
44.
TorresCA, Medina-KirchnerC, O'MalleyKY, et al.Totality of the evidence suggests prenatal cannabis exposure does not lead to cognitive impairments: A systematic and critical review. Front Psychol, 2020; 11:816; doi: 10.3389/fpsyg.2020.00816
45.
Young-WolffKC, TuckerL-Y, AlexeeffS, et al.Trends in self-reported and biochemically tested marijuana use among pregnant females in California from 2009–2016. JAMA, 2017; 318(24):2490–2491.
46.
National Academies of Sciences, Engineering, and Medicine. Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. The National Academies Press: Washington, DC, USA; 2017.
47.
ShionoPH, KlebanoffMA, NugentRP, et al.The impact of cocaine and marijuana use on low birth weight and preterm birth: A multicenter study. Am J Obstet Gynecol, 1995; 172(1 Pt 1):19–27.
48.
Young-WolffKC, AdamsSR, WiS, et al.Routes of cannabis administration among females in the year before and during pregnancy: Results from a pilot project. Addict Behav, 2020; 100:106125; doi: 10.1016/j.addbeh.2019.106125
49.
CorsiDJ, DonelleJ, SuchaE, et al.Maternal cannabis use in pregnancy and child neurodevelopmental outcomes. Nat Med, 2020; 26(10):1536–1540; doi: 10.1038/s41591-020-1002-5
50.
KotoP, AllenVM, FaheyJ, et al.Maternal cannabis use during pregnancy and maternal and neonatal outcomes: A retrospective cohort study. BJOG, 2022; 129(10):1687–1694; doi: 10.1111/1471-0528.17114
51.
SassoEB, BolshakovaM, BogumilD, et al.Marijuana use and perinatal outcomes in obstetric patients at a safety net hospital. Eur J Obstet Gynecol Reprod Biol, 2021; 266:36–41; doi: 10.1016/j.ejogrb.2021.09.015
52.
BaileyBA, WoodDL, ShahD. Impact of pregnancy marijuana use on birth outcomes: Results from two matched population-based cohorts. J Perinatol, 2020; 40(10):1477–1482; doi: 10.1038/s41372-020-0643-z
53.
GabrhelikR, MahicM, LundIO, et al.Cannabis use during pregnancy and risk of adverse birth outcomes: A longitudinal cohort study. Eur Addict Res, 2021; 27(2):131–141; doi: 10.1159/000510821
54.
KlebanoffMA, WilkinsDG, KeimSA. Marijuana use during pregnancy and preterm birth: A prospective cohort study. Am J Perinatol, 2021; 38(Suppl. 01):e146–e154; doi: 10.1055/s-0040-1708802
55.
LeeE, PluymID, WongD, et al.The impact of state legalization on rates of marijuana use in pregnancy in a universal drug screening population. J Matern Fetal Neonatal Med, 2022; 35(9):1660–1667; doi: 10.1080/14767058.2020.1765157
56.
WongSPW, TwynstraJ, GillilandJA, et al.Risk factors and birth outcomes associated with teenage pregnancy: A canadian sample. J Pediatr Adolesc Gynecol, 2020; 33(2):153–159; doi: 10.1016/j.jpag.2019.10.006
57.
HowardDS, DhanrajDN, DevaiahCG, et al.Cannabis use based on urine drug screens in pregnancy and its association with infant birth weight. J Addict Med, 2019; 13(6):436–441; doi: 10.1097/ADM.0000000000000516
58.
KharbandaEO, Vazquez-BenitezG, Kunin-BatsonA, et al.Birth and early developmental screening outcomes associated with cannabis exposure during pregnancy. J Perinatol, 2020; 40(3):473–480; doi: 10.1038/s41372-019-0576-6
59.
LukeS, HutcheonJ, KendallT. Cannabis use in pregnancy in British Columbia and selected birth outcomes. J Obstet Gynaecol Can, 2019; 41(9):1311–1317; doi: 10.1016/j.jogc.2018.11.014
60.
RodriguezCE, SheederJ, AllshouseAA, et al.Marijuana use in young mothers and adverse pregnancy outcomes: A retrospective cohort study. BJOG, 2019; 126(12):1491–1497; doi: 10.1111/1471-0528.15885
61.
StraubHL, MouJ, DrennanKJ, et al.Maternal marijuana exposure and birth weight: An observational study surrounding recreational marijuana legalization. Am J Perinatol, 2021; 38(1):65–75; doi: 10.1055/s-0039-1694793
62.
WallKM, HaddadLB, MehtaCC, et al.Miscarriage among women in the United States Women's Interagency HIV Study, 1994–2017. Am J Obstet Gynecol, 2019; 221(4):347 e1–e347 e13; doi: 10.1016/j.ajog.2019.05.034
63.
Coleman-CowgerVH, OgaEA, PetersEN, et al.Prevalence and associated birth outcomes of co-use of Cannabis and tobacco cigarettes during pregnancy. Neurotoxicol Teratol, 2018; 68:84–90; doi: 10.1016/j.ntt.2018.06.001
64.
MasseySH, MroczekDK, ReissD, et al.Additive drug-specific and sex-specific risks associated with co-use of marijuana and tobacco during pregnancy: Evidence from 3 recent developmental cohorts (2003–2015). Neurotoxicol Teratol, 2018; 68:97–106; doi: 10.1016/j.ntt.2018.06.002
65.
SerinoD, PetersonBS, RosenTS. Psychological functioning of women taking illicit drugs during pregnancy and the growth and development of their offspring in early childhood. J Dual Diagn, 2018; 14(3):158–170; doi: 10.1080/15504263.2018.1468946
66.
Dotters-KatzSK, SmidMC, ManuckTA, et al.Risk of neonatal and childhood morbidity among preterm infants exposed to marijuana. J Matern Fetal Neonatal Med, 2017; 30(24):2933–2939; doi: 10.1080/14767058.2016.1269165
67.
ChabarriaKC, RacusinDA, AntonyKM, et al.Marijuana use and its effects in pregnancy. Am J Obstet Gynecol, 2016; 215(4):506.e1–506.e7; doi: 10.1016/j.ajog.2016.05.044
68.
LeemaqzSY, DekkerGA, McCowanLM, et al.Maternal marijuana use has independent effects on risk for spontaneous preterm birth but not other common late pregnancy complications. Reprod Toxicol, 2016; 62:77–86; doi: 10.1016/j.reprotox.2016.04.021
69.
MarkK, DesaiA, TerplanM. Marijuana use and pregnancy: Prevalence, associated characteristics, and birth outcomes. Arch Women Ment Health, 2016; 19(1):105–111; doi: 10.1007/s00737-015-0529-9
70.
WarshakCR, ReganJ, MooreB, et al.Association between marijuana use and adverse obstetrical and neonatal outcomes. J Perinatol, 2015; 35(12):991–995; doi: 10.1038/jp.2015.120
71.
GrayTR, EidenRD, LeonardKE, et al.Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth. Clin Chem, 2010; 56(9):1442–1450; doi: 10.1373/clinchem.2010.147876
72.
SchempfAH, StrobinoDM. Illicit drug use and adverse birth outcomes: Is it drugs or context?. J Urban Health, 2008; 85(6):858–873; doi: 10.1007/s11524-008-9315-6
73.
LozanoJ, Garcia-AlgarO, MarcheiE, et al.Prevalence of gestational exposure to cannabis in a Mediterranean city by meconium analysis. Acta Paediatr, 2007; 96(12):1734–1737; doi: 10.1111/j.1651–2227.2007.00535.x
74.
BurnsL, MattickRP, CookeM. The use of record linkage to examine illicit drug use in pregnancy. Addiction, 2006; 101(6):873–882; doi: 10.1111/j.1360-0443.2006.01444.x
75.
BadaHS, DasA, BauerCR, et al.Low birth weight and preterm births: Etiologic fraction attributable to prenatal drug exposure. J Perinatol, 2005; 25(10):631–637; doi: 10.1038/sj.jp.7211378
76.
ReichmanNE, TeitlerJO. Effects of psychosocial risk factors and prenatal interventions on birth weight: Evidence from New Jersey's HealthStart program. Perspect Sex Reprod Health, 2003; 35(3):130–137; doi: 10.1111/j.1931-2393.2003.tb00133.x
77.
QuinlivanJA, EvansSF. The impact of continuing illegal drug use on teenage pregnancy outcomes—A prospective cohort study. BJOG, 2002; 109(10):1148–1153; doi: 10.1111/j.1471-0528.2002.01536.x
78.
BerensonAB, WilkinsonGS, LopezLA. Effects of prenatal care on neonates born to drug-using women. Subst Use Misuse, 1996; 31(8):1063–1076; doi: 10.3109/10826089609072288
79.
CorneliusMD, TaylorPM, GevaD, et al.Prenatal tobacco and marijuana use among adolescents: Effects on offspring gestational age, growth, and morphology. Pediatrics, 1995; 95(5):738–743.
80.
KliegmanRM, MaduraD, KiwiR, et al.Relation of maternal cocaine use to the risks of prematurity and low birth weight. J Pediatr, 1994; 124(5 Pt 1):751–756; doi: 10.1016/s0022-3476(05)81370-8
81.
RichardsonGA, DayNL, TaylorPM. The effect of prenatal alcohol, marijuana, and tobacco exposure on neonatal behavior. Infant Behav Dev, 1989; 12(2):199–209; doi: 10.1016/0163-6383(89)90006-4
82.
HayesJS, DreherMC, NugentJK. Newborn outcomes with maternal marihuana use in Jamaican women. Pediatr Nurs, 1988; 14(2):107–110.
83.
KlineJ, SteinZ, HutzlerM. Cigarettes, alcohol and marijuana: Varying associations with birth weight. Int J Epidemiol, 1987; 16(1):44–51; doi: 10.1093/ije/16.1.44
84.
HatchEE, BrackenMB. Effect of marijuana use in pregnancy on fetal growth. Am J Epidemiol, 1986; 124(6):986–993; doi: 10.1093/oxfordjournals.aje.a114488
85.
TennesK, AvitableN, BlackardC, et al.Marijuana: Prenatal and postnatal exposure in the human. NIDA Res Monogr, 1985; 59:48–60.
86.
GibsonGT, BaghurstPA, ColleyDP. Maternal alcohol, tobacco and cannabis consumption and the outcome of pregnancy. Aust N Z J Obstet Gynaecol, 1983; 23(1):15–19; doi: 10.1111/j.1479-828x.1983.tb00151.x
87.
GreenlandS, StaischKJ, BrownN, et al.The effects of marijuana use during pregnancy. I. A preliminary epidemiologic study. Am J Obstet Gynecol, 1982; 143(4):408–413; doi: 10.1016/0002-9378(82)90082-5
88.
FriedPA. Marihuana use by pregnant women: Neurobehavioral effects in neonates. Drug Alcohol Depend, 1980; 6(6):415–424; doi: 10.1016/0376-8716(80)90023-x
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
